PerkinElmer To Acquire Lifescience Firm BioLegend For $5B; Q2 Earnings Beat Estimates
PerkinElmer Inc’s (NYSE:PKI) has agreed to acquire privately-held BioLegend for $5.25 billion in cash and stock. The BioLegend deal will expand PerkinElmer’s existing…